Search Page

1

Cite

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease.

Cummings J, Osse AML, Cammann D, Powell J, Chen J. Cummings J, et al. Among authors: cammann d. BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13. BioDrugs. 2024. PMID: 37955845 Free PMC article. Review.

Cite

2

Cite

Genetic correlations between Alzheimer's disease and gut microbiome genera.

Cammann D, Lu Y, Cummings MJ, Zhang ML, Cue JM, Do J, Ebersole J, Chen X, Oh EC, Cummings JL, Chen J. Cammann D, et al. Sci Rep. 2023 Mar 31;13(1):5258. doi: 10.1038/s41598-023-31730-5. Sci Rep. 2023. PMID: 37002253 Free PMC article.

Cite

3

Cite

Drug repurposing for Alzheimer's disease and other neurodegenerative disorders.

Cummings JL, Zhou Y, Van Stone A, Cammann D, Tonegawa-Kuji R, Fonseca J, Cheng F. Cummings JL, et al. Among authors: cammann d. Nat Commun. 2025 Feb 19;16(1):1755. doi: 10.1038/s41467-025-56690-4. Nat Commun. 2025. PMID: 39971900 Free PMC article. Review.

Cite

4

Cite

Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data.

Zhan H, Cammann D, Cummings JL, Dong X, Chen J. Zhan H, et al. Among authors: cammann d. J Transl Med. 2025 Mar 6;23(1):278. doi: 10.1186/s12967-025-06317-5. J Transl Med. 2025. PMID: 40050982 Free PMC article.

Cite

5

Cite

Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development.

Cummings JL, Osse AML, Kinney JW, Cammann D, Chen J. Cummings JL, et al. Among authors: cammann d. CNS Drugs. 2024 Aug;38(8):613-624. doi: 10.1007/s40263-024-01103-1. Epub 2024 Jun 27. CNS Drugs. 2024. PMID: 38937382 Free PMC article. Review.

Cite

6

Cite

The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities.

Arruda AL, Bocher O, Taylor HJ, Cammann D, Yoshiji S, Yin X, Zhao C, Chen J, Wood AC, Suzuki K, Mercader JM, Spracklen CN, Meigs JB, Vujkovic M, Smith GD, Rotter JI, Voight BF, Morris AP, Zeggini E. Arruda AL, et al. Among authors: cammann d. medRxiv [Preprint]. 2025 May 7:2025.05.05.25326966. doi: 10.1101/2025.05.05.25326966. medRxiv. 2025. PMID: 40385452 Free PMC article. Preprint.

Cite

7

Cite

Polygenic scores and Mendelian randomization identify plasma proteins causally implicated in Alzheimer's disease.

Cammann DB, Lu Y, Rotter JI, Wood AC, Chen J. Cammann DB, et al. Front Neurosci. 2024 Jul 23;18:1404377. doi: 10.3389/fnins.2024.1404377. eCollection 2024. Front Neurosci. 2024. PMID: 39108314 Free PMC article.

Cite

8

Cite

Shared Genetic Architecture Between COVID-19 Severity and Alzheimer's Disease Across European and African Ancestries.

Chen J, Cammann D, Liu T, Liu Y, Cummings M, Chen X, Oh E, Rotter J. Chen J, et al. Among authors: cammann d. Res Sq [Preprint]. 2024 Dec 24:rs.3.rs-5619229. doi: 10.21203/rs.3.rs-5619229/v1. Res Sq. 2024. PMID: 39764106 Free PMC article. Preprint.

Cite

9

Cite

Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues.

Bocher O, Arruda AL, Yoshiji S, Zhao C, Su CY, Yin X, Cammann D, Taylor HJ, Chen J, Suzuki K, Mandla R, Huerta-Chagoya A, Yang TY, Matsuda F, Mercader JM, Flannick J, Meigs JB, Wood AC, Vujkovic M, Voight BF, Spracklen CN, Rotter JI, Morris AP, Zeggini E. Bocher O, et al. Among authors: cammann d. medRxiv [Preprint]. 2025 May 7:2025.05.05.25326880. doi: 10.1101/2025.05.05.25326880. medRxiv. 2025. PMID: 40385441 Free PMC article. Preprint.

Cite